This paper uses the latest data from the Organization for Economic Cooperation and Development (OECD) to compare the health systems of the thirty member countries in 2000. Total health spending--the distribution of public and private health spending in the OECD countries--is presented and discussed. U.S. public spending as a percentage of GDP (5.8 percent) is virtually identical to public spend...

The health care system in China has been undergoing reforms for the past three decades. New policies and regulations are being developed to better meet the health needs of over a billion people. As reform programs expand, the need for scientific evidence increases, to enable accurate evaluation of the impact of new policies. In this context, health economics and outcomes research (HEOR) will be...

BACKGROUND Interest and participation in global health activities among U.S. medical trainees has increased sharply in recent decades, yet the global health activities of physicians who have completed residency training remain understudied. Our objectives were to assess associations between individual characteristics and patterns of post-residency global health activities across the domains of ...

background: a dramatic increase in healthcare expenditures is a major health policy concern worldwide. understanding factors that underlie the growth in healthcare expenditures is essential to assist decision-makers in finding best policies to manage healthcare costs. we aimed to examine the determinants of healthcare spending in iran over the periods of 1978-2011. methods: a time series analys...

background: to achieve development goals in a country, having a research plan is necessary. need assessment in health is the first stage of research priority aiming improves health condition in a population. the objective of this study was to determine a list of research projects according to the health problems priority in ramadan province, iran. methods: to determine research priorities in th...

Across the DRGs studied, the average allowed amounts varied, ranging from around $5,000 (DRG 312 in 2010; Table 1) to over $30,000 (DRG 247 in 2014; Table 2). In the population covered by ESI, the average allowed amount for each DRG studied was Growing interest in health care price transparency has led to research focused on the impact of consumers “shopping” for health care.1 Less attention ha...

In the nearly 18 months that have elapsed following enactment of the Patient Protection and Affordable Care Act (PPACA), health care scholars have debated a key portion of the legislation that has the potential to dramatically impact health care. Section 6301 of the PPACA outlines how the federal government will play an increasingly direct role in shaping comparative effectiveness research (CER...

OBJECTIVES The aim of this study was to evaluate the impact of reductions in statin and clopidogrel copayments on cardiovascular resource utilization, major coronary events, and insurer spending. BACKGROUND Copayments are widely used to contain health spending but cause patients to reduce their use of essential cardiovascular medications. Reducing copayments for post-myocardial infarction sec...